Skip to main content
Advertisement

Bristol Myers Squibb

Patient Support Services

Abecma

(idecabtagene vicleucel)
Disease Type(s)
Multiple myeloma

Cell Therapy 360

Abraxane

(paclitaxel protein-bound particles)
Disease Type(s)
Breast Cancer
Lung Cancer
Pancreatic cancer

BMS Access Support

Augtyro

(repotrectinib)
Disease Type(s)
Lung Cancer
Solid tumors

BMS Access Support

Breyanzi

(lisocabtagene maraleucel)

Cell Therapy 360

Empliciti

(elotuzumab)
Disease Type(s)
Multiple myeloma

BMS Access Support

Idhifa

(enasidenib)

BMS Access Support

Inrebic

(fedratinib)
Disease Type(s)
Myelofibrosis

BMS Access Support

Onureg

(azacitidine)

BMS Access Support

Opdivo

(nivolumab)
Disease Type(s)
Melanoma
Lung Cancer
Kidney Cancer
Malignant pleural mesothelioma
Hodgkin lymphoma
Head and Neck Cancer
Bladder and Urothelial cancer
Colorectal cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Gastroesophageal junction cancer

BMS Access Support

Opdivo Qvantig

(nivolumab and hyaluronidase-nvhy)
Disease Type(s)
Melanoma
Lung Cancer
Kidney Cancer
Malignant pleural mesothelioma
Hodgkin lymphoma
Head and Neck Cancer
Bladder and Urothelial cancer
Colorectal cancer
Liver Cancer
Esophageal Cancer
Gastric Cancer
Gastroesophageal junction cancer
Mesothelioma

BMS Access Support

Opdualag

(nivolumab and relatlimab-rmbw)

BMS Access Support

Pomalyst

(pomalidomide)
Disease Type(s)
Multiple myeloma
Sarcoma

BMS Access Support

Reblozyl

(luspatercept-aamt)

BMS Access Support

Revlimid

(lenalidomide)
Disease Type(s)
Multiple myeloma

BMS Access Support

Sprycel

(dasatinib)

BMS Access Support

Thalomid

(thalidomide)
Disease Type(s)
Multiple myeloma

BMS Access Support

Yervoy

(ipilimumab)
Disease Type(s)
Melanoma
Kidney Cancer
Lung Cancer
Malignant pleural mesothelioma
Colorectal cancer
Liver Cancer

BMS Access Support

Zenbexus

(iberdomide)
Disease Type(s)
Multiple myeloma

BMS Access Support


Interested in
Advertising with Us?

Lorem ipsum dolor sit amet consetetur sadipscing elitr sed diam nonumy eirmod tempor invidunt ut.
Advertisement
Advertisement
Advertisement